SPL Numero 15 :) MaxCyte, Inc., a leading provider of enabling platform technologies for ex-vivo cell engineering, today announces the signing of a strategic platform license (SPL) with Nkarta, Inc., …
Bild: 20286_20210730221802_maxcyte_dreckskacke :rolleyes: